| Dr Debra R Judelson, MD | |
|
414 N Camden Dr, Ste 1100, Beverly Hills, CA 90210-4532 | |
| (310) 278-3400 | |
| (310) 278-1240 |
| Full Name | Dr Debra R Judelson |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 414 N Camden Dr, Beverly Hills, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790757136 | NPI | - | NPPES |
| 00G351610 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | G35161 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Debra R Judelson, MD 414 N Camden Dr, Ste 1100, Beverly Hills, CA 90210-4532 Ph: (310) 278-3400 | Dr Debra R Judelson, MD 414 N Camden Dr, Ste 1100, Beverly Hills, CA 90210-4532 Ph: (310) 278-3400 |
News Archive
The U.S. government, through the U.S. Agency for International Development (USAID), announced over $10.5 million in grants to seven organizations working in six countries in Africa to extend malaria prevention and control activities in communities most affected by the disease, particularly children under age 5 and pregnant women.
Fibrocell Science, Inc. announced today that is has submitted to the U.S. Food & Drug Administration (FDA) the company's Phase II clinical study protocol to evaluate the safety and efficacy of Fibrocell's lead therapy, azficel-T, in improving the range of motion, function and flexibility, in patients with existing restrictive burn scars.
Individuals with brain injury and their families often struggle to accept the associated personality changes. The behavior of individuals with acquired brain injury (ABI) is typically associated with problems such as aggression, agitation, non-compliance, and depression. Treatment goals often focus on changing the individual's behavior, frequently using consequence-based procedures or medication. In the current issue of NeuroRehabilitation leading researchers challenge this approach and recommend moving emphasis from dysfunction to competence.
A team of UK biotech experts are close to delivering a sophisticated and affordable testing technology that will complement the simple binary COVID-19 tests currently in use.
Living Cell Technologies Limited today announced that the first patient has been successfully implanted in the Phase I clinical trial of the regenerative cell therapy NTCELL – a potential treatment for Parkinson's disease.
› Verified 3 days ago
Igor Gorokhov, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 9400 Brighton Way, Suite 410, Beverly Hills, CA 90210 Phone: 310-256-2426 Fax: 310-954-9373 | |
Miss Pritha Payel Gupta, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 8641 Wilshire Blvd Ste 115, Beverly Hills, CA 90211 Phone: 310-855-7002 Fax: 310-855-7003 | |
Daniel Benhuri, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 9400 Brighton Way, Beverly Hills, CA 90210 Phone: 310-683-0180 | |
Dr. Seymour Levine, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 150 North Robertson Blvd, #350, Beverly Hills, CA 90211 Phone: 310-687-2855 Fax: 310-687-7433 | |
Dr. Reed Scott Wilson, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 435 N Roxbury Dr, Suite #300, Beverly Hills, CA 90210 Phone: 310-859-9170 | |
Dr. Alex Foxman, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 8920 Wilshire Blvd Ste 310, Beverly Hills, CA 90211 Phone: 310-274-0657 Fax: 310-274-6083 | |
Dr. Raymond Zimmer, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 8501 Wilshire #150, Beverly Hills, CA 90211 Phone: 310-358-3496 Fax: 310-247-9614 |